GLP-1 Tirzepatide vial — Calabasas Longevity

GLP-1 + GIP Medication

Tirzepatide

Dual-pathway appetite and fullness regulation targeting both GLP-1 and GIP receptors — physician-supervised, pharmacy-grade, pre-mixed.

✓Pre-mixed compounded peptide — no BAC water, no reconstituting
✓Licensed US 503A compounding pharmacy
✓Physician-reviewed and prescribed
✓Weekly care team check-ins included

Dose selection

You can change or cancel your program at any time. A physician will determine what's appropriate for you.

View cart →
A licensed physician will review your intake and determine if this program is right for you. A $20 physician review fee is collected separately at intake. Program fee is fully refunded if not approved — physician fee is non-refundable.

What is Tirzepatide?

Tirzepatide is a dual GIP and GLP-1 receptor agonist — the first of its class to target both incretin hormone pathways simultaneously. By activating both GIP and GLP-1 receptors, it supports appetite control, fullness cues, and metabolic balance through complementary mechanisms.

At Calabasas Longevity, Tirzepatide is available as a pre-mixed compounded injectable — physician-prescribed and sourced from a licensed US 503A compounding pharmacy. No reconstituting required.

Who typically explores this program

  • Individuals needing advanced appetite and fullness support
  • Clients with long-term difficulty controlling cravings
  • Those in structured, comprehensive weight-management programs
  • People who have plateaued on other GLP-1 approaches

Why pre-mixed matters. Most peptides sourced online arrive as lyophilized powder requiring reconstitution with bacteriostatic water — introducing contamination risk and dosing variability. Our compounded peptides arrive ready to inject, prepared under pharmaceutical-grade conditions by a licensed 503A pharmacy. Same compound. Dramatically higher safety standard.

Mechanisms of action

Tirzepatide's dual mechanism targets both the GLP-1 and GIP receptors. GLP-1 activation supports appetite suppression and slows gastric emptying, while GIP receptor activation has been shown to complement these effects and may improve insulin sensitivity and fat metabolism through distinct pathways.

Medication overview: Tirzepatide is a prescription medication that acts on GIP and GLP-1 receptors involved in appetite regulation and glucose metabolism.

Research context

  • Medication safety: Do not change the amount used, use the medication more frequently, or share it with another person.
  • Side effects: Potential side effects include nausea, diarrhea, vomiting, constipation, abdominal discomfort, indigestion, fatigue, and injection-site reactions.

All prescribing decisions are made by your physician based on your individual health history and clinical presentation. Nothing here constitutes medical advice.

01
Add to your program
Select your duration and add Tirzepatide to your cart. Combine with other programs in one order.
02
Complete your intake
You'll receive a secure intake link. A physician reviews your health history and determines clinical appropriateness.
03
Pharmacy ships
If approved, your pre-mixed compounded program ships from a licensed US 503A pharmacy within 24–48 hours.
04
Weekly check-ins
Ongoing care team check-ins are included. All clinical questions go directly to your physician.
Physician determination: Calabasas Longevity is a wellness membership and referral platform — not a medical practice. All prescribing decisions are made independently by licensed physicians. We cannot guarantee a prescription will be issued. A full refund is provided if your physician does not approve your program.